血液透析患者相关并发症和中性粒细胞与淋巴细胞比值关系的研究进展
Research progress in the relationship between hemodialysis-related complications and neutrophil/lym-phocyte ratio in hemodialysis patients
李甜 1伍杨 2何喜梅 1万立平 1王学良 1苑书婷 1席春生3
作者信息
- 1. 730000 兰州,甘肃中医药大学第一临床医学院;730050 兰州,中国人民解放军联勤保障部队第九四○医院肾脏病科
- 2. 730000 兰州,甘肃中医药大学第一临床医学院
- 3. 730050 兰州,中国人民解放军联勤保障部队第九四○医院肾脏病科
- 折叠
摘要
近年来,中性粒细胞与淋巴细胞比值(neutrophil to lymphocyte ratio,NLR)已被公认为一种新型预测生物标志物,由于其创伤小、经济、简便、敏感性和特异性高等优点,在心血管疾病、肾脏疾病、自身免疫性疾病等预后指标中广泛应用.血液透析(haemodialysis,HD)作为危重症或晚期肾病患者延长寿命的治疗手段,不可避免会导致很多并发症,因此及时识别和治疗HD相关并发症至关重要.有研究发现在HD相关并发症中NLR似乎具有一定的识别和预测能力,故本综述通过总结当前HD患者相关并发症中NLR研究进展,为临床医生评估HD患者相关并发症的发生和预后提供依据.
Abstract
Currently,neutrophils to lymphocytes ratio(NLR)has been recognized as a new predictive biomarker,and is widely used as a prognostic indicator for cardiovascular diseases,renal diseases,autoim-mune diseases and others because it is less traumatic,economic,simple,high sensitive and specific.Hemodial-ysis(HD)is one of the essential measures for critically ill and end-stage renal disease patients to prolong their-lives,but many complications occur inevitably.Early identification and treatment of theses complications are required.Previous studies have found that NLR may have the abilities to recognize and predict HD-related complications.This review summarizes the research progress in NLR changes in HD-related complications,to provide a basis for clinicians to evaluate the presence and prognosis of HD-related complications.
关键词
血液透析/中性粒细胞与淋巴细胞比值/并发症/研究进展Key words
Hemodialysis/Neutrophil to lymphocyte ratio/Complications/Research progress引用本文复制引用
基金项目
甘肃省卫生健康行业科研项目(GSWSKY2022-51)
联勤保障部队第九四〇医院专项(2022yxky017)
出版年
2024
NETL
NSTL
万方数据